Peripheral Neurophathies Associated With Chronic Renal Failure
.
INTRODUCTION
Charcot and Osier clearly suspected the existence of uremic neuropathy, but at that time metabolic disturbances and coma dominated the clinical picture of terminal renal failure and neuropathy was easily overlooked. Not until 1963 (Asbury et al.) were the detailed clinical and pathological features fully described. This report will summarize my observations since 1966 and relate them to the pertinent literature, emphasizing the different varieties of peripheral nerve disorder, neurophysiological tests, and the effects of various treatments on the course of uremic polyneuropathy. Uremic polyneuropathy may occur at any age, once the degree of renal failure is sufficient. It is, inexplicably, commoner in males than females (Asbury, 1975) . The prevalence of signs and symptoms, and the order of their appearance have a similar pattern (Figure 1 ), one that is common to many distal, motor and sensory polyneuropathies. The variable progress (Figure 2 ) is only partly explained by types of dialysis procedure, intercurrent illness, and effects of renal transplantation. Rarely, the condition becomes crippling, with all limbs weak and wasted, deep tendon reflexes absent, and all sensation lost in a stocking-glove pattern.
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Of the associated neuropathic syndromes, the burning foot syndrome was initially common. It resulted from the water soluble vitamin B, being removed during hemodialysis, but with replacement this syndrome is now rare. The restless leg syndrome and muscle cramps are common, but both may not be due to neuropathy (Nielsen, 1971) . Autonomic neuropathy undoubtedly occurs, as shown in physiological studies by Kersh et al. (1974) , and by the involvement of nonmyelinated fibers (Dyck et al., 1971) . However, it is usually clinically insignificant. In unselected patients (Figure 1 ), sweating in fingers and toes tested by the ninhydrin method and postural changes in blood pressure were normal.
A Guillain-Barre type of neuropa- Figure 3 -Comparison of median nerve conduction results in a healthy person and a patient with mild uremic neuropathy, both females of similar age and height. All results are from supramaximal stimuli at the wrist. Note prolonged latencies and reduced and dispersed action potentials on antidromic sensory, and orthodromic motor conduction in uremia. The F response latency, representing time of antidromic motor conduction to anterior horn cells and then orthodromic conduction down motor axons to thenar muscle, in a measure of both proximal and distal conduction times.
thy termed "monophasic motor neuropathy" is also rare. It may be uremic polyneuropathy with prominent motor manifestations and acute onset, or an autoimmune neuropathy predisposed to by immunodeficiency associated with renal failure. The differentiation is difficult because the CSF protein is elevated in most patients with uremic neuropathy (Jennekins et al., 1971) , simulating the "albumino-cytologic" dissociation of Guillain-Barre syndrome. Compression of the ulnar nerve at the elbow, or the peroneal nerve at the fibular head, occasionally occurs in cachectic patients recumbent for long periods. The carpal tunnel syndrome may occur distal to forearm arteriovenous fistulas used for access during hemodialysis, presumably because of distal ischemia or edema (Harding and Le Fanu, 1977) . Excessive arteriovenous shunting from a bovine shunt located in the upper arm may cause permanent ischemic neuropathy (Bolton et al., 1979 b) . The bleeding tendency associated with uremia or with anticoagulant therapy may cause psoas muscle hematoma with femoral nerve compression, requiring surgical decompression.
Nitrofurantoin, less commonly pencillin G, causes a polyneuropathy with clinical features similar to uremic polyneuropathy but electrophysiological and pathological features suggest a purely axonal degeneration. Kanamycin, Gentamycin, etc., cause a similar neuropathy or a defect in neuromuscular transmission. Nielsen (1972) found nerve conduction velocities to be a sensitive test for uremic neuropathy. Reduced velocities often precede either symptoms or signs (Table 2; Figure 1 ). They reflect the clinical course of uremic neuropathy (Figure 2 ), the degree of paranodal and segmental demyelination, and segmental remyelination (Bolton et al., 1979 c) and, perhaps, the adequacy of hemodialysis . Excessive variation in serial tests of the same patient (Kominami et al., 1971) can be reduced by attention to technical detail.
NEUROPHYSIOLOGICAL TESTS
Prolonged distal latencies ( Figure 3 ) are due to involvement of distal nerve segments; dispersed compound action potentials are due to paranodal and segmental demyelination; and reduced compound action potential amplitudes are due mainly to reduced density of large myelinated motor Early experience with chronic hemodialysis suggested that the degree of merit (Figure 6 ), greater residual renal function, de-ionisation or reverse osmosis of water for dialysis, less infection using arteriovenous fistulas instead of shunts, and earlier transplantation in uncontrolled uremic toxicity are other explanations.
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To more thoroughly investigate the relationship between chronic hemodialysis methods and uremic neuropathy, 30 patients in London, Ontario, underwent a series of investigations. The neuropathy was assessed by serial, clinical, and nerve conduction studies. Eighteen were dialyzed 2 times weekly on a hospital program and 12, 3 times weekly on a home program. The two groups had the same incidence and course (Table 2) , even though patients on the home program had a better feeling of well-being, less anemia, and improved platelet function. The neuropathy in both groups stabilized but did not improve and two patients in each regressed, one on the home program becoming quadriplegic. Since the two groups were not strictly comparable, ten were selected from each who were similar in age, initial severity of neuropathy, and total duration of chronic hemodialysis but no significant differences in neuropathy were demonstrated (Figure 5 b, c) . Then, the home and
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hospital groupings were discarded and the middle molecule clearance (see above : Babb et al., 1971) and final conduction velocity were compared in each of the 30 patients (Figure 7) . While the resulting positive linear regression line was statistically insignificant, it suggests a trend requiring further investigation. Finally, using the patient as his own control, six, whose neuropathy was stable for two years, were switched from 2 times to 3 times weekly hemodialysis; nerve conduction studies every four months for one year on this group and six healthy controls were unchanged for conduction velocity, F response latency, or muscle and sensory compound action potential amplitude.
Thus, modern methods of managing renal failure have clearly decreased the incidence of uremic neuropathy and chronic hemodialysis stabilizes this condition in most patients, improving or worsening it in a few (Figure 2) . However, the course of the neuropathy cannot be improved with certainty by manipulating the hemodialysis schedule, at least within the limits of current practice. Nor are standard nerve conduction studies a reliable method of determining the adequacy of hemodialysis, other systemic evidence of uremic toxicity appearing earlier, as shown in our studies and in a recent study by Dyck et al. (1979) . Blair (1977) has compared patients, on peritoneal hemodialysis to those on hemodialysis. The results for chronic hemodialysis were similar to our London patients, the neuropathy stabilizing at two standard deviations below mean control values. However, the neuropathy tended to worsen slowly during peritoneal dialysis. These results are notable since one might have expected the neuropathy to improve, the peritoneal membrane being more selective in passing various molecular weight substances, including "middle molecules", than the artificial membrane in hemodialysis machines (Asbury, 1975) .
Initially, the degree of improvement in neuropathy after successful renal transplantation was questioned (Merrill and Hampers, 1970) , particularly if the neuropathy was severe . However, remarkable improvement in symptoms, signs, and nerve conduction studies occurred in ten patients, three with severe neuropathy, after this procedure (Bolton et al., 1970 . Subjective improvement began within one month, and although recovery was prolonged beyond two years in severe cases, none was left with a significant disability. A disabling action tremor in another patient, presumably secondary to severe neuropathy, eventually disappeared after full recovery (Casano, 1972) .
Nerve conduction velocities show a rapid rise initially, particularly in milder neuropathies (Figure 2 e, f)> levelling off later (Dobblestein et al., 1968) . Paranodal remyelination by still viable Schwann cells likely explain the early rise and segmental remyelination by intercalation of new Schwann cells Allt, 1960) explains both the late rise and restitution of dispersed action potentials (Bolton etal., 1971; . Surprisingly, conduction velocities may rise within a few days of successful renal transplantation, Oh et al. (1978) speculating a metabolic cause.
If the transplanted kidney undergoes late failure, uremic neuropathy may develop a second time, but be reversed by a further successful renal transplant . This fluctuation is related to the functional state of the transplanted kidney and not to prednisone and immunosuppressive drugs used routinely after surgery to prevent or to treat rejection .
PATHOPHYSIOLOGY AND ETIOLOGY The peripheral nerves show distal segmental demyelination and axonal degeneration, and the spinal cord, chromotolysis of anterior horn cells (Asbury and al., 1973) . Severe demyelination of lumbosacral nerve roots may occur in advanced neuropathy (Bolton and Rozdilsky, 1971) . Teased fiber studies reveal paranodal demyelination, segmental demyelination, axonal degeneration, and segmental remyelination (Figure 8 ). Quantitative studies show a reduction of large and small myelinated and unmyelinated fibers (Dyck et al., 1971) . However, all pathological observations to date have been nonspecific (Asbury, 1975) .
Mechanisms underlying the neuropathy are unknown. Teased fiber techniques (Dinn and Crane, and Dayan et al., 1970) , light and electron microscopy, and biochemical dialysis by gas liquid chromotography of whole peripheral nerves (Appenzeller et al., 1971) suggested Schwann cell dysfunction was the primary event. However, Dyck et al. (1971) and Thomas et al. (1971) suggested segmental demyelination was secondary to a primary axonal degeneration. The ratio of the circumference of axis cylinders to the number of myelin lamellae was decreased in distal nerve fibers, suggesting axon shrinkage. Segmental demyelination tended to occur only on certain fibers, completely sparing others, suggesting that demyelination was secondary to axonal disease. Demyelination and axonal degeneration were much more severe distally.
However, in the early stage of uremic neuropathy, there is slowing of conduction in proximal and distal shows teased fiber results for two nerves biopsied at the ankle in a sixty-five year old woman on twice weekly GambroLundia Nova dialyzer for 18 months, who had a mild, stable polyneuropathy.
portions of peripheral nerves (Nielsen, 1973) and an electrodecremental response typical of that seen when normal human nerves are rendered ischemic (Nielsen, 1974) . Nielsen explained
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Neuropathy and Chronic Renal Failure both by an inhibition of sodium potassium activated ATPase at the nerve axon membrane. Perhaps membrane dysfunction is occurring at the perineurium which functions as a diffuse barrier between interstitial fluid and nerve, or in blood capillaries within the endoneurium, which act as barriers between blood and nerve. As a result, uremic toxins might enter the endoneural space at either site and not only cause direct nerve damage, but also water and electrolyte shifts with expansion or retraction of this space. Since the amplitude of sensory compound action potentials is positively related to the density of myelinated nerve fibers (Lambert and Dyck, 1975) , such endoneural volume changes would affect this density and may explain alterations in these amplitudes observed in uremia: their failure to decrease during limb ischemia, enhanced by a single hemodialysis procedure and abolished by macromolecular perfusion (Castaigne et al., 1972) ; or their rise after a single hemodialysis procedure (Stanley et al., 1972) .
The nature of the toxic substance, or substances, in uremia is also unknown. Deficiency of thiamine, magnesium, or erythrocyte transketolase (an enzyme in the pentose phosphate shunt, particularly concentrated in myelin-rich areas of the nervous system) is unproven (Asbury, 1975 ). An accumulation of toxins is more likely. Urea and creatinine, of low molecular weight, are effectively reduced by hemodialysis, but their concentrations bear a poor relationship to neuropathy. Myoinosital, molecular weight 180, a precursor of phosphoinositide, is rapidly metabolized in neural membranes. It is abnormally elevated in chronic renal failure, poorly eliminated by hemodialysis, but, being normally excreted by renal cortex, is handled effectively by a successfully transplanted kidney. Thus, Clements et al., (1973) , suggested it was the peripheral nerve toxin. They found reversible reduction in conduction velocities of experimental animals fed excessive amounts of myoinosital. However, Reznek et al. (1977) demonstrated no convincing relationship between human uremic neuropathy and plasma myoinosital levels.
The "middle molecule" theory is currently the most plausible (Babb et al., 1971) . These substances, molecular weight 300 to 2,000, are abnormally elevated in end-stage renal failure, and, while not greatly reduced by chronic hemodialysis, are more effectively reduced by parallel plate (Kiil) dialyzing units than coil (Kolff) dialyzers. When detected by in vitro chromotographic fractionation, they correlate with the degree of neurotoxicity, shown by a bioassay method (Funck-Brentano et al., 1978) . The transplanted kidney deals effectively with substances of wide ranging molecular weights, the resulting elimination of middle molecules explaining the invariable improvement in neuropathy after transplant (Editorial, 1971) .
